July 1, 2010
Covance is one of the world’s largest and most comprehensive drug development services companies with more than 10,000 employees in 60 countries. Through its comprehensive portfolio of services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.
Working with clients of all sizes, Covance recognizes that your development program is as unique as the product you bring to our facilities. With over 250 different biomolecules successfully supported annually, Covance Biopharmaceutical Services provide you with a global, multidisciplinary team of experts and specialized state-of-the-art infrastructure to help achieve your development and commercialization goals.
The comprehensive Covance biopharmaceutical service capabilities include extensive expertise and experience in:
cGMP batch release
Protein chemistry
Biological assays
Adventitious agent testing
Biomanufacturing support
cGMP cell bank production and storage
cGMP stability studies
Immunocharacterization
Molecular biology
Viral clearance studies
Covance has a complementary portfolio of discovery, nonclinical safety assessment, clinical development, periapproval, and market access capabilities for full development of biopharmaceutical products.
In an industry where the process is the product, the scientific and regulatory expertise and experience, accumulated and proven through decades of hands-on development of a wide variety of molecules and numerous submissions, make Covance the partner of choice for biopharmaceutical development.
Discovery
Development
Commercialization
Research
Preclinical
Phase 1
Phase 2
Phase 3
Phase 4
IND/CTA
POC
NDA/MAA/BLA
Product characterization, stability, and purity- indicating method development
Product and dose analysis and release
Analytical stability and release for clinical trials
Commercial stability and release
Cell-based bioassay development
Bioassays for stability and release
Biodistribution studies of gene therapy products
Preformulations
Formulations
Cell-line screening and other biosafety testing, including virus and other adventitious agent testing
Cell banking and characterization
Cell banking
Viral clearance studies
Biomanufacturing and Process Development Support
Project Management
Program Management
Integrated Drug Development
Global, flexible offerings of individual services, milestone-based solutions, and full development solutions
About the Author
Author Details
Ji Wu, PhD, Marketing Manager, Covance, 3301 Kinsman Blvd, Madison, WI 53704, USA; [email protected], +1-888-268-2623.
You May Also Like